BackExscientia Plc Overview

Exscientia Plc Receivables

Latest receivables for EXAI: $50M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$49.62M
29.43% YoYΔ $-20.70M vs prior year quarter

Peer trimmed avg / median

Loading

Exscientia Plc Receivables History

Loading

Exscientia Plc vs. peers: Receivables Comparison

Loading

Exscientia Plc Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Exscientia Plc (EXAI) FAQ

Exscientia Plc's receivables stands at $50M as of September 2024. That compares with $70M in the prior-year period — down 29.4% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Exscientia Plc reported $50M in receivables versus $70M a year earlier — a 29.4% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $70M in the prior-year period — down 29.4% year over year. Sustained growth in receivables can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Exscientia Plc's receivables evolved across reporting periods, while the comparison chart places EXAI next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, receivables is commonly used to spot outliers. Exscientia Plc's reading of $50M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.